ContractRespireRx Pharmaceuticals Inc. • February 2nd, 2024 • Pharmaceutical preparations • New York
THIS NOTE AND THE CONVERSION SHARES HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED, OR ANY STATE SECURITIES LAWS. THIS NOTE AND THE CONVERSION SHARES MAY NOT BE SOLD, OFFERED FOR SALE, PLEDGED OR HYPOTHECATED IN THE ABSENCE OF AN EFFECTIVE REGISTRATION STATEMENT AS TO THIS NOTE AND THE CONVERSION SHARES UNDER SAID ACT AND ANY APPLICABLE STATE SECURITIES LAWS OR AN OPINION OF COUNSEL (WHICH COUNSEL SHALL BE SELECTED BY HOLDER), IN A GENERALLY ACCEPTABLE FORM THAT REGISTRATION IS NOT REQUIRED UNDER SAID ACT.
DEBT SETTLEMENT AGREEMENTDebt Settlement Agreement • February 2nd, 2024 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations
This DEBT SETTLEMENT AGREEMENT (the “Agreement”), is made this 30th day of January 2024, by and between RespireRx Pharmaceuticals Inc (“Borrower”), and [xxx] (“Holder”):
DEBT SETTLEMENT AGREEMENTDebt Settlement Agreement • February 2nd, 2024 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations
This DEBT SETTLEMENT AGREEMENT (the “Agreement”), is made this 30th day of January 2024, by and between RespireRx Pharmaceuticals Inc (“Borrower”), and [xxx] (“Holder”):
DEBT SETTLEMENT AGREEMENTDebt Settlement Agreement • February 2nd, 2024 • RespireRx Pharmaceuticals Inc. • Pharmaceutical preparations
This DEBT SETTLEMENT AGREEMENT (the “Agreement”), is made this 30th day of January 2024, by and between RespireRx Pharmaceuticals Inc (“Borrower”), and [xxx] (“Holder”):
